histone lysine methyltransferase NSD2 inhibitors (Inventiva)

N/A

Report date: 2025/03/20 15:19:42
NME

Base Information

Drug Namehistone lysine methyltransferase NSD2 inhibitors (Inventiva)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase NSD2 inhibitors
TargetsHistone-lysine N-methyltransferase NSD2
Therapy Area/IndicationsMultiple MyelomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInventiva SA
China Registration ClassN/A

Develop Information

Active CompaniesInventiva SA
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A